Kolinsky Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Kolinsky Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-473	Closed	-$230K	–	180
2024 Q2	$230K	Sell	473 -11	-2%	-$5.52K	0.17%	132
2024 Q1	$261K	Sell	484 -17	-3%	-$9.29K	0.2%	114
2023 Q4	$278K	Sell	501 -86	-15%	-$40.4K	0.24%	102
2023 Q3	$257K	Sell	587 -7	-1%	-$3.49K	0.25%	94
2023 Q2	$294K	Sell	594 -17	-3%	-$8.15K	0.28%	85
2023 Q1	$306K	Sell	611 -38	-6%	-$18.2K	0.32%	75
2022 Q4	$265K	Buy	+649	New	+$252K	0.3%	89
2022 Q2	–	Sell	-412	Closed	-$225K	–	132
2022 Q1	$225K	Buy	412 +79	+24%	+$41.6K	0.22%	120
2021 Q4	$219K	Buy	+333	New	+$209K	0.2%	133

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kolinsky Wealth Management's IDXX Position: Q3 2024 in Review

Kolinsky Wealth Management sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 473 shares — an estimated $230K sold.

Kolinsky Wealth Management first reported a position in IDXX in Q4 2021 and held it in 9 quarters. The position peaked at $306K in Q1 2023. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

Kolinsky Wealth Management reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
Kolinsky Wealth Management sold 473 Idexx Laboratories shares in Q3 2024, an estimated $230K.
Kolinsky Wealth Management first reported a position in Idexx Laboratories in Q4 2021 and held it in 9 quarters.
Kolinsky Wealth Management's Idexx Laboratories position peaked at $306K in Q1 2023.
1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Kolinsky Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.